Your browser doesn't support javascript.
loading
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.
de Boer, S M; Wortman, B G; Bosse, T; Powell, M E; Singh, N; Hollema, H; Wilson, G; Chowdhury, M N; Mileshkin, L; Pyman, J; Katsaros, D; Carinelli, S; Fyles, A; McLachlin, C M; Haie-Meder, C; Duvillard, P; Nout, R A; Verhoeven-Adema, K W; Putter, H; Creutzberg, C L; Smit, V T H B M.
Afiliación
  • de Boer SM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: s.m.de_boer.onco@lumc.nl.
  • Wortman BG; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Powell ME; Department of Clinical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London.
  • Singh N; Department of Cellular Pathology, Barts Health NHS Trust, Royal London Hospital, London, UK.
  • Hollema H; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.
  • Wilson G; Department of Pathology, Central Manchester Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Manchester, UK.
  • Chowdhury MN; Department of Cellular Pathology, Barts Health NHS Trust, Royal London Hospital, London, UK.
  • Mileshkin L; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Pyman J; Department of Anatomical Pathology, Royal Women's Hospital, Parkville, Australia.
  • Katsaros D; Department of Surgical Sciences, Az O-Universitaria Città della Salute di Torino, Torino, Italy.
  • Carinelli S; Division of Pathology and Laboratory Medicine, European Institute of Pathology, Milan, Italy.
  • Fyles A; CCTG, Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.
  • McLachlin CM; Department of Pathology and Laboratory Medicine, Western University, London, Canada.
  • Haie-Meder C; Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.
  • Duvillard P; Department of Pathology, Institut Gustave Roussy, Villejuif, France.
  • Nout RA; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Verhoeven-Adema KW; Central Trials Office, Comprehensive Cancer Center The Netherlands, Leiden, The Netherlands.
  • Putter H; Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
  • Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Ann Oncol ; 29(2): 424-430, 2018 02 01.
Article en En | MEDLINE | ID: mdl-29190319
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Selección de Paciente Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Selección de Paciente Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article